TargetMol

Datelliptium chloride hydrochloride

Product Code:
 
TAR-T7747
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7747-1mg1mg£650.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7747-5mg5mg£1,340.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7747-10mg10mg£1,910.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7747-25mg25mg£3,259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7747-50mg50mg£5,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7747-100mg100mg£8,022.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Datelliptium chloride hydrochloride is a DNA-intercalating agent derived from ellipticine. with anti-tumor activities.
CAS:
157000-76-5
Formula:
C23H29Cl2N3O
Molecular Weight:
434.41
Pathway:
DNA Damage/DNA Repair; Cell Cycle/Checkpoint
Purity:
0.9991
SMILES:
Cl.[Cl-].CCN(CC)CC[n+]1ccc2c(C)c3[nH]c4ccc(O)cc4c3c(C)c2c1
Target:
DNA/RNA Synthesis

References

Mucci-Lorusso P , Polin L , Biernat L A , et al. Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice[J]. Investigational New Drugs, 1990, 8(3):253-261. Khayat D , Borel C , Azab M , et al. Phase I study of Datelliptium chloride, hydrochloride given by 24-h continuous intravenous infusion[J]. Cancer Chemotherapy and Pharmacology, 1992, 30(3):226-228.